ROS/mtROS promotes TNTs formation via PI3K/AKT/mTOR pathway to protect against mitochondrial damages induced by engineering nanomaterialsin human glial cells

Author:

Lin Xinpei1,Wang Wei1,Chang Xiangyu1,Chen Cheng1,Guo Zhenkun1,Yu Guangxia1,Shao Wenya1,Wu Siying1,Zhang Qunwei2,Zheng Fuli1,Li Huangyuan1

Affiliation:

1. Fujian Medical University

2. University of Louisville

Abstract

Abstract Background As the demand and application of engineering nanomaterials rise, their potential toxicity in the central nervous system has drawn increasing concerns. As a novel cell-cell communication, tunneling nanotubes (TNTs) plays a crucial role in pathology and physiology. Unfortunately, the relationship between TNTs and nanomaterials neurotoxicity remains scarce. Here, three types of commonly used engineering nanomaterials, Cobalt nanoparticles (CoNPs), titanium dioxide nanoparticles (TiO2NPs), and multi-walled carbon nanotubes (MWCNTs) were selected to address this limitation. Results After complete characterization of the nanomaterials, the induction of TNTs formation by all of the nanomaterials was observed by high-content screening system and confocal microscopy in both primary astrocyte and U251 cells. The positive role of TNTs formation was further unveiled, which protected against the nanomaterials-induced neurotoxicity from cell apoptosis to ATP production dysfunction. We then ought to determine the underline mechanism of TNTs positive role. Since the generation of oxidative stress is a common mechanism in nanotoxicity, we first observed a significant increase in total and mitochondrial reactive oxygen species (namely ROS, mtROS), causing mitochondrial damage. Moreover, the pretreatment of U251 cells with either a ROS scavenger N-acetylcysteine or a mtROS scavenger mitoquinone attenuated the nanomaterial-induced neurotoxicity and TNTs generation, suggesting the central role of ROS in nanomaterials-induced TNTs formation. Furthermore, a vigorous downstream pathway of ROS, i.e., PI3K/AKT/mTOR pathway was found to be actively involved in the nanomaterials-promoted TNTs development, which was abolished by LY294002, Perifosine and Rapamycin, the inhibitors of PI3K, AKT, and mTOR, respectively. Finally, Western blot analysis demonstrated that ROS and mtROS scavenger suppressed PI3K/AKT/mTOR pathway, which then abrogated TNTs formation. Conclusion Our findings indicate that various types of nanomaterials promote TNTs formation through the generation of ROS/mtROS and the activation of downstream PI3K/AKT/mTOR pathway, which could fight against cell apoptosis and ATP production dysfunction induced by nanomaterials. Our study contributes to a better understanding of the intercellular protection mechanism against neurotoxicity induced by various kinds of nanomaterials, and sheds light on potential treatments to activate the cell-cell defense system against environmental toxicants.

Publisher

Research Square Platform LLC

Reference42 articles.

1. Occupational Exposures to Engineered Nanomaterials: a Review of Workplace Exposure Assessment Methods;McCormick S;Curr Environ Health Rep,2021

2. Nanomaterials Market Size, Share & Growth [2023 Report]. Accessed July 28., 2023. https://www.grandviewresearch.com/industry-analysis/nanotechnology-and-nanomaterials-market.

3. ltd R, Global M, Report CCobaltI. 2021–2026. Accessed July 30, 2023. https://www.researchandmarkets.com/reports/5561716/global-and-china-cobalt-industry-report-2021-2026.

4. Engineered nanomaterials and human health: Part 1. Preparation, functionalization and charact-erization (IUPAC Technical Report). Chemistry International. 2018;40(4):34–34. doi:doi:10.1515/ci-2018-0424.

5. Shape-controlled synthesis and properties of uniform spinel cobalt oxide nanocubes;Liu X;Nanotechnology,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3